Transcriptome sequencing datasets showed that the expression levels of CD39/CD73/ADA1/ADA2 were often changed in immune cells from SLE patients, while the expression of adenosine receptors were not changed (Fig. 2, Fig. 3). This evidence concerns the gene ADA2 and systemic lupus erythematosus.